This review summarizes current concepts in the anatomic classification, pathophysiology, natural history, and clinical management of bicuspid aortic valve disease and associated ascending aortic aneurysms.
Answers are grounded in this paper and cite their sources.
Offers updated synthesis for bicuspid aortic valve management; leaves open optimal intervention thresholds for prospective validation.
The bicuspid aortic valve is the most common congenital cardiac anomaly in developed nations. The abnormal bicuspid morphology of the aortic valve results in valvular dysfunction and subsequent hemodynamic derangements. However, the clinical presentation of bicuspid aortic valve disease remains quite heterogeneous with patients presenting from infancy to late adulthood with variable degrees of valvular stenosis and insufficiency and associated abnormalities including aortic coarctation, hypoplastic left heart structures, and ascending aortic dilatation. Emerging evidence suggests that the heterogeneous presentation of bicuspid aortic valve phenotypes may be a more complex matter related to congenital, genetic, and/or connective tissue abnormalities. Optimal management of patients with BAV disease and associated ascending aortic aneurysms often requires a thoughtful approach, carefully assessing various risk factors of the aortic valve and the aorta and discerning individual indications for ongoing surveillance, medical management, and operative intervention. We review current concepts of anatomic classification, pathophysiology, natural history, and clinical management of bicuspid aortic valve disease with associated ascending aortic aneurysms.
No takes yet. Share an insight, caveat, or question.
Losenno et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: